Device
Nautilus NeuroWaveTM System
Nautilus NeuroWaveTM System is a medical device with 3 clinical trials. Historical success rate of 66.7%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
1(33%)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
66.7%
Trials by Status
terminated133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
terminated
Study to Test Sensitivity and Specificity of Passive Wave Pressure Device in Determining Ischemic Stroke
NCT01643525
completed
Concussion Testing: A Novel Non-invasive Concussion Detection Device
NCT02370914
completed
Dementia Signal Development Study of Nautilus NeuroWave TM for the Detection of Dementia
NCT02333942
Clinical Trials (3)
Showing 3 of 3 trials
NCT01643525
Study to Test Sensitivity and Specificity of Passive Wave Pressure Device in Determining Ischemic Stroke
NCT02370914
Concussion Testing: A Novel Non-invasive Concussion Detection Device
NCT02333942
Dementia Signal Development Study of Nautilus NeuroWave TM for the Detection of Dementia
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3